CBD Research
Below is a list of just some of the clinical and other research that has been published surrounding the potential medical and therapeutic benefits of CBD:
Antibacterial
Antioxidant
- Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
- Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver
Anxiety
- Action of Cannabidiol on the Anxiety and Other Effects Produced by D9-THC in Normal Subjects
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
- Effects of Cannabidiol (CBD) on Regional Cerebral Blood
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Asthma
- Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Autoimmune
- Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice
- Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol
Digestion
- Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
- Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
Immunity
- Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
- Interaction Between The Protective Effects Of Cannabidiol And Palmitoylethanolamide In Experimental Model Of Multiple Sclerosis In C57BL/6 Mice
Inflammation
- Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
- Cannabidiol (CBD) and its analogs: A review of their effects on inflammation
- Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
- Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
- Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
- Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
Memory
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
Mental Illness
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- Cannabidiol as a potential treatment for psychosis
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice
- Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report - ResearchGate
- Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
Nausea
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
- Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
Pain
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
- Overcoming the Bell‐Shaped Dose‐Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
- Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
- The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
- The Endocannabinoid System, Cannabinoids, and Pain
- The endogenous cannabinoid system and its role in nociceptive behavior
- Cannabinoid–Opioid Interaction in Chronic Pain
- Cannabinoid receptors and pain
- Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain
- Cannabinoids for Neuropathic Pain
- Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
- Cannabinoids in the management of difficult to treat pain
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors